275

Studies in recent years show that bacterial vaginosis is a disease that can cause serious reproductive health problems and complications of pregnancy. The question of the choice of the drug, especially in the first trimester of pregnancy, when the use of antibacterial therapy is limited, remains an urgent problem. An alternative and optimal option for the treatment of bacterial vaginosis in pregnant women in the first trimester of pregnancy is a seven-day course of treatment with local use of ascorbic acid, which by the end of treatment in 88.9% of pregnant women forms vaginal normocenosis.

  • Internet havola
  • DOI10.26739/2181-9300-2018-4-3
  • UzSCI tizimida yaratilgan sana 25-11-2019
  • O'qishlar soni 0
  • Nashr sanasi 19-12-2018
  • Asosiy tilIngliz
  • Sahifalar
English

Studies in recent years show that bacterial vaginosis is a disease that can cause serious reproductive health problems and complications of pregnancy. The question of the choice of the drug, especially in the first trimester of pregnancy, when the use of antibacterial therapy is limited, remains an urgent problem. An alternative and optimal option for the treatment of bacterial vaginosis in pregnant women in the first trimester of pregnancy is a seven-day course of treatment with local use of ascorbic acid, which by the end of treatment in 88.9% of pregnant women forms vaginal normocenosis.

Русский

Исследования последних лет показывают, что бактериальный вагиноз – это заболевание, которое может вызывать серьезные нарушения репродуктивного здоровья женщины и осложнения беременности. Вопрос выбора препарата, особенно в первом триместре беременности, когда ограничены возможности применения антибактериальной терапии остается актуальной проблемой. Альтернативным и оптимальным вариантом лечения бактериального вагиноза у беременных в I триместре беременности является семидневный курс лечения местным применением аскорбиновой кислоты, который к концу лечения у 88,9% беременных формирует нормоценоз влагалища.

№ Muallifning F.I.Sh. Lavozimi Tashkilot nomi
1 Rakhmatullaeva M.M.
2 Gafarova S.U.
3 Soliyeva .K.
№ Havola nomi
1 1.Voroshilina, E. S., Tumbinskaya, L. V., Donnikov, A. E., Plotko, E. EH., & Hayutin, L. V. (2010). Biocenoz vlagalishcha s tochki zreniya kolichestvennoj PCR: izmeneniya i korrekciya vo vremya beremennosti [Vaginal biocenosis in terms of quantitative PCR: changes and correction during pregnancy]. Ural’skij medicinskij zhurnal, 3(68), 108.
2 2.Melkumyan, A. R., Priputnevich, T. V., Ankirskaya, A. S., Trofimov, D. YU., Murav’eva, V. V., Mullabaeva, S. M., & Zav’yalova, M. G. (2013). Vidovoj sostav laktobakterij pri razlichnom sostoyanii mikrobioty vlagalishcha u beremennyh [The species composition of lactobacilli in various states of the vaginal microbiota in pregnant women]. Klinicheskaya mikrobiologiya i antimikrobnaya himioterapiya, 15(1), 72.
3 3.Safronova, M. M., & Grenkova, YU. M. (2009). Narushenie sostoyaniya vlagalishchnogo mikrobiocenoza: sovremennye metody korrekcii [Violation of the state of vaginal microbiocenosis: modern methods of correction]. Klinicheskaya dermatologiya i venerologiya, (6), 102-106.
4 4.Usova, M. A. (2010). Kliniko-diagnosticheskie aspekty disbioza vlagalishcha i terapiya bakterial’nogo vaginoza u zhenshchin v rannie sroki beremennosti [Clinical and diagnostic aspects of vaginal dysbiosis and treatment of bacterial vaginosis in women in early pregnancy]. Diss. kand. med. nauk. Samara.
5 5.Roberts, C. L., Morris, J. M., Rickard, K. R., Giles, W. B., Simpson, J. M., Kotsiou, G., & Bowen, J. R. (2011). Protocol for a randomised controlled trial of treatment of asymptomatic candidiasis for the prevention of preterm birth [ACTRN12610000607077]. BMC pregnancy and childbirth, 11(1), 19.
Kutilmoqda